Home

CJ Der

Lab Members Research

Publications

CCBTP

Resources

Contact

Channing J. Der, PhD

Professor of Pharmacology at UNC-CHSchool of Medicine

Director, NIH Predoctoral Cancer Cell Biology Training Program

Member, Lineberger Comprehensive Cancer Center Research

Member, Curriculum in Genetics and Molecular Biology

Member, Curriculum in Toxicology

Member, Center for Gastrointestinal Biology 

Member, Biological and Biomedical Sciences  Program

EDUCATION

1981-1985

Harvard Medical School (Pathology) and Dana-Farber Cancer Institute (Postdoctoral Fellowship)

1981  Ph.D.

University of California, Irvine (Microbiology

1975  B.A.

University of California, Los Angeles (Biology)

PROFESSIONAL EXPERIENCE

2012 - 2013

President, Cancer Biology Training Consortium

2010 - 2013

Board of Directors, Cancer Biology Training Consortium

2010

Consultant, Bristol-Myers Squibb

2010

Consultant, AstraZeneca

2010

Consultant, Sanofi-Aventis

2010 - 2012

Chair, Pancreatic Cancer Action Network-AACR Innovative Grants Scientific Review Committee

2010 - 2011

AACR Program Committee

2009 - present

Editorial Board, Bioscience Reports

2009 - present

Editorial Board, Small GTPases

2009 - present

Editorial Board, Genes & Cancer

2008

Senior Academic Visitor of Wolfson College, Cambridge, UK

2008 - present

Scientific Advisory Board, Lustgarten Foundation for Pancreatic Cancer Research

2008 - present

Consultant, Millipore

2007 - 2011

Reviewer, Italian Association Cancer Research

2007 - 2008

AACR Program Committee

2007 - 2008

Member, Children’s Tumor Foundation, Drug Discovery Initiative Panel

2007

Member, AACR Grants Subcommittee for Pancreatic Cancer Research Fellowship

2006 - 2009

Member, DOD Neurofibromatosis Research Program Integration Panel

2006 - present

Editorial Board, Journal Molecular Signaling

2004 - 2007

AACR Laboratory Research Awards Selection Committee

2005 - present

Member, Cancer Biology Training Consortium

2003

Consultant, Chemicon

2003

Consultant, Upstate Biotechnology

2003

Consultant, Odyssey Thera

2002

Consultant, PPD Discovery

2001- present

Member, Faculty of 1000

2001

External Reviewer, Wake Forest Cancer Center Program

2000 - 2002

Associate Editor, Cancer Research

2000 - present

Editorial Board, Cancer Letters

2000 - present

Consultant, Tularik

1998 - present

Director, NIH Cancer Cell Biology Training Grant

1998 - present

Board of Advisors, Children’s Tumor Foundation

1998 - present

Member, Curriculum in Toxicology, UNC-Chapel Hill

1998

Consultant, Schering-Plogh

1997                       

Consultant, Dupont-Merck

1996 - 1997

Consultant, Biomeasure

1996

Consultant, Merck

1995 -1996

Consultant, Parke-Davis

1995 - present

Professor, Department of Pharmacology, Member, UNC Lineberger Comprehensive Cancer Center and Member, Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill

1992-1995

Associate Professor, Department of Pharmacology, Member, UNC Lineberger Comprehensive Cancer Center and Member, Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill

1992-1996

Member, NIH Pathology B Study Section

1992-1994

Consultant, Bristol-Myers Squibb

1992-1993

Consultant, Dupont Merck Pharmaceuticals

1991-1993

Consultant, Eisai Research Institute

1990-present

Consultant, Special Review Committee, NCI

1989-1991

Ad Hoc Member, NIH Pathology B Study Section

1989-1992

Staff Scientist, The Burnham Institute

1985-1989

Assistant Staff Scientist, The Burnham Institute

1981-1985

Postdoctoral Fellow, Harvard Medical School and the Dana-Farber Cancer Institute

HONORS AND AWARDS

Recipient, Lauds & Laurels, Distinguished Alumni Award, University of California, Irvine (2012) Keynote Speaker, Ras-Like GTPases and Tumor Suppressors: Are We Ready For Translation? Tel Aviv, Israel (2012)

Keynote Speaker, Fayetteville State University-SPIRE Cancer Symposium (2011)

Keynote Speaker, Mayo Clinic Graduate Student Retreat (2011)

Recipient, Hyman L. Battle Distinguished Cancer Research Award (2011)

Keynote Speaker, 16th International AEK Cancer Congress, Düsseldorf, Germany (2011)

Keynote Speaker, International Symposium on RASSF Family of Tumor Suppressor Proteins, Calgary, Canada (2009)

Keynote Speaker, Annual Cancer Center Retreat, Wake Forest University (2009)

Organizer, Cold Spring Harbor/Banbury Lustgarten KRAS Think Tank, Cold Spring Harbor, NY (2008)

Keynote Speaker, Annual Meeting of the Pharmaceutical Society of Korea, Jeju Island, Korea (2008)

Co-Organizer, Lustgarten/AACR Pancreatic Cancer Meeting, Chapel Hill, NC (2006)

Sarah Graham Kenan Distinguished Professorship (2006)

Keynote Speaker, FASEB Summer Research Conference, Saxton River, VT (2006)

Co-Chair, CNIO Cancer Conference, Madrid, Spain (2003)

Co-Organizer, Annual Oncogene Meeting, Frederick, MD (2003)

Keynote Speaker, MIT/Neurofibromatosis Foundation Consortium Meeting, Cambridge, MA (1999)

Organizer, NIEHS Symposium on Small GTPases and Cancer, Research Triangle Park, NC (1998)

Keynote Speaker, First Mark Roth Memorial Lecture, Ann Arbor, MI (1997)

Co-Chair, FASEB Summer Research Conference, Saxton River, VT (1991)

Recipient, American Cancer Society Faculty Research Award (1990-1995)

Recipient, NRSA Postdoctoral Fellowship (1985-86)

Recipient, Damon Runyon-Walter Winchell Postdoctoral Fellowship (1983-85)